Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,3,8-Triuazaspiro(4,5)decanone compounds as ORL1-receptor agonists

1,3,8-Triuazaspiro(4,5)decanone compounds as ORL1-receptor agonists

US Patent 6465478 · Granted Oct 15, 2002

Estimated economic value: $179,452,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hard surface detergent composition2021
Detergent composition for hard surfaces2019
N-substituted spiropiperidine compounds as ligands for ORL-1 receptor2005
Benzimidazole compounds as ORL1-receptor agonists2005
Benzimidazole compounds as ORL1-receptor agonists2005
Process for preparing hydroxypyrrolidinyl ethylamine compounds useful as kappa a2003
4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists2002
4-(2-keto-1-benzimidazolinyl)piperidine compounds as ORL1-receptor agonists2002
2-benzimidazolylamine compounds as ORL-1-receptor agonists2002
Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists2001
Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists2001
Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists2001